Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep355 | Clinical case reports - Thyroid/Others | ECE2016

Amiodarone - induced type 2 thyrotoxicosis in patient with ESRD treated with hemodialysis

Kurowska Maria , Malicka Joanna , Bober-Palak Ewa , Lewicki Marcin , Tarach Jerzy S.

Introduction: Type 2 amiodarone-induced thyrotoxicosis (AIT2), resulting from the release of thyroid hormones, is a rarer form of side effect of this drug. Treatment of thyrotoxicosis in patients with end stage renal disease (ESRD) is difficult because hemodialysis alters renal clearance of drugs and iodine, may impact the results of assessment and treatment and can increase the medical instability of patients.Aim: The aim was to present the difficulties...

ea0037ep931 | Thyroid (non-cancer) | ECE2015

The efficacy of radioiodine therapy in patients with non-toxic nodular goitre with large cold nodule

Abdelrazek Saeid , Szumowski Piotr , Siewko Katrzyna , Mysliwiec Janusz , Szelachowska Malgorzata , Garkowski Marcin

Most of the patients with the benign cold nodule refuse surgical operation. Radioiodine therapy (RIT) is the choice for these patients. The aim of our study was to evaluate the efficacy of radioiodine therapy to reduce thyroid volume in patients with cold nodule by the use of two doses of radioiodine.Methods: We treated 40 patients with non-toxic nodular goitre with large cold nodule, aged 18 and 48 years; initial 24 h radioiodine uptake (RAIU) was range...

ea0035p303 | Clinical case reports Thyroid/Others | ECE2014

A patient with lung ectopic parathyroid coexistent with primary hyperparathyroidism and end-stage renal diseases

Kowalska Beata , Lomna-Bogdanov Elzbieta , Pukajlo Katarzyna , Kaluzny Marcin , Jedrzejuk Diana , Doskocz Krzysztof

We report the case of 57-year-old man with end-stage renal disease, primary hyperparathyroidism and after an surgery of upper parathyroid glands with ectopic parathyroid localized in lung. Patient was directed to our hospital to perform diagnostics on hyperparathyroidism. Two years earlier (2011) patient was hospitalized because of weakness and weight loss, and was diagnosed with primary hyperparathyroidism. In 2012 he underwent the bilateral parathyroidectomy of upper glands ...

ea0035p682 | Growth hormone IGF axis basic | ECE2014

Evaluation of the effect of X chromosome abnormalities on the response to GH therapy in children with turner syndrome

Kasprzyk Jakub , Wlodarczyk Marcin , Sobolewska Aleksandra , Glusinska Sylwia , Stawerska Renata , Hilczer Maciej , Lewinski Andrzej

Introduction: Turner syndrome (TS) is a condition caused by structural or numerical abnormalities of X chromosome. Growth deficiency is characteristic for patients with TS, and particular karyotype abnormalities of the X chromosome may be associated with different responsiveness to human GH (hGH) therapy. The aim of the study was to determine the effect of TS karyotype on growth velocity during hGH therapy in TS.Methods: 23 TS patients treated with hGH w...

ea0035p818 | Paediatric endocrinology | ECE2014

Analysis of Th17 cells and IL17, IL23 cytokines in peripheral blood from children with autoimmune thyroid disease

Bossowski Artur , Moniuszko Marcin , Dabrowska Milena , Jeznach Marta , Rusak Malgorzata , Bossowska Anna

Up till now, altered balance of T helper 1 (Th1) and Th2 immune cells has been postulated to play an important role in the pathogenesis of autoimmune thyroid diseases (AITD). However, recent studies on thyroid diseases suggest a new role for Th17 (T helper 17) cells which have the ability to secrete cytokines: IL17, IL17F, IL21, and IL23. The aim of the study was to estimate the proporcions of circulating CD4+CD161+CD196+ and CD4+IL17+ Th17 cells and serum concentrations of IL...

ea0070aep109 | Adrenal and Cardiovascular Endocrinology | ECE2020

Case study of family performing pheochromocytoma and paraganglioma (PPGL)

Tywanek Ewa , Zwolak Agnieszka , Wozniak Magdalena , Lewicki Marcin , Matyjaszek-Matuszek Beata

Introduction: Phaeochromocytomas are mostly benign tumours with origin from chromaffin tissue of adrenal glands, whereas paragangliomas aretumours located along the sympathetic or/and the parasympathetic chain. Generally they are quite rare neoplasms with ability of producing, storing and secreting of catecholamines. Predominatingly they are sporadic, but in some cases they may develop in progress of particular genetic syndromes, such as multiple endocrine neoplasia type 2 (ME...

ea0070aep797 | Reproductive and Developmental Endocrinology | ECE2020

Ovarian reserve and serum concentration of thyroid peroxidase antibodies in euthyroid women with different polycystic ovary syndrome phenotypes

Adamska Agnieszka , Lebkowska Agnieszka , Krentowska Anna , Pliszka Justyna , Adamski Marcin , Leśniewska Monika , Kowalska Irina

Objective: It has been shown that women with PCOS as well as with autoimmune thyroiditis (AIT), are characterized by increased incidence of infertility. Serum anti-Müllerian hormone (AMH), which reflects ovarian reserve, is elevated in PCOS women and is decreased in women with AIT. The Rotterdam criteria recognize four clinical PCOS phenotypes,i.e.,phenotype Acharacterized by clinical and/or biochemical hyperandrogenism (HA), menstrual dysfunction (oligo/amenorrhea) (Olig...

ea0026p152 | Male reproduction | ECE2011

Expression of ghrelin receptor GHSR-1a in mammalian spermatozoa and their response to ghrelin in vitro

Lukaszyk Andrzej , Kotwicka Malgorzata , Jankowska Anna , Rucinski Marcin , Kasprzak Aldona , Sterzynska Karolina , Ziolkowska Agnieszka , Ruchala Marek

In this study, we attempted to demonstrate the expression of GHSR-1a receptor and possible effects of its activation in human, rat and boar spermatozoa. For demonstration of GHSR-1a immunocytochemical, immunofluorescence and western blotting techniques were applied. The effects of receptor activation was tested in a series of in vitro incubations of spermatozoa with or without addition of ghrelin and the effects were evaluated using confocal microscopy and flow cytometr...

ea0016p278 | Endocrine tumours | ECE2008

The enzymatic activity of type 1 iodothyronine deiodinase (D1) is low in large intestine metastases into liver

Debski Marcin , Kornasiewicz Oskar , Stepnowska Marta , Szalas Anna , Krawczyk Marek , Bar-Andziak Ewa

Type 1 iodothyronine deiodinase (D1) is responsible for the conversion of thyroxin (T4) into tri-iodothyronine (T3). The enzyme is mainly present in thyroid, liver and kidneys.There is strong evidence that the metabolism of thyroid hormones is disturbed in some neoplasmatic tissues. However there are only few available data about D1 enzymatic activity in liver tumors.The aim of this study was to estimate the e...

ea0016p280 | Endocrine tumours | ECE2008

Type 1 iodothyronine deiodinase (D1) enzymatic activity is not reduced in liver focal nodular hyperplasia (FNH)

Szalas Anna , Stepnowska Marta , Debski Marcin , Kornasiewicz Oskar , Krawczyk Marek , Bar-Andziak Ewa

FNH is the second most common benign liver tumor caused mainly by oral contraceptives. D1, which is a crucial enzyme in catalyzing prohormone thyroxine (T4) into active triiodothyronine (T3), is mainly present in such tissues as thyroid, liver and kidney. There are only few data about D1 enzymatic activity in neoplasmatic conditions. Mostly in tumors reduced D1 activity was found.The aim of the study was to examine the activity of t...